Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Presenter: Mustafa Suppah

June 08, 2023

Presentation TVT 2023

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Presenter: Brian Whisenant

June 08, 2023

Presentation TVT 2023

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Presenter: Olayiwola Bolaji

June 08, 2023

Presentation TVT 2023

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

Presenter: Veronica Andre

June 08, 2023

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

Presentation TVT 2022

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Presenter: Amar Krishnaswamy

June 10, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Todd Neale

July 28, 2021

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Todd Neale

July 22, 2021

Presentation TVT 2021

PFO Closure and Atrial Fibrillation

Presenter: Robert Sommer

July 22, 2021

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Hyungdon Kook

June 14, 2019

Presentation TVT 2019

Operator and Institutional Requirements for LAA Occlusion for Non-Valvular Atrial Fibrillation

Presenter: Hemal Gada

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Critical Appraisal of the Advantages and Limitations of Warfarin, NOACs, and Ablation in Patients With Non-Valvular Atrial Fibrillation

Presenter: DJ Lakkireddy

June 13, 2019

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Advertisement

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

Minorities, Poorer Patients Missing Out on Structural Heart Care

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

More Support for Single Antiplatelet Therapy After TAVI

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

PFO Closure and Atrial Fibrillation

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Operator and Institutional Requirements for LAA Occlusion for Non-Valvular Atrial Fibrillation

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Critical Appraisal of the Advantages and Limitations of Warfarin, NOACs, and Ablation in Patients With Non-Valvular Atrial Fibrillation

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content